Evidence map›Paper›PMID 36547735›Full record

ArticleJournal of patient-reported outcomes2022

Assessing the collection and reporting of patient-reported outcome data in interventional cancer trials: a single institution, retrospective systematic evaluation.

Emma Lidington, Holly Hogan, Ann Gandolfi, Jane Lawrence, Eugenie Younger, Helena Cho, Clare Peckitt, Kabir Mohammed, Sheila Matharu, Lisa Scerri and 4 more

Open access · goldAbstract read
In one paragraph

Article in Journal of patient-reported outcomes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
1.2field-weighted citation impact, top 21% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Guideline
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 2 institutions in 1 country.

Emma LidingtonPROFILES Team, The Royal Marsden NHS Foundation Trust, London, UK. emma.lidington@kcl.ac.uk.ORCID http://orcid.org/0000-0001-6176-8054
Holly HoganPROFILES Team, The Royal Marsden NHS Foundation Trust, London, UK.
Ann GandolfiResearch & Development, The Royal Marsden NHS Foundation Trust, London, UK.
Jane LawrenceResearch & Development, The Royal Marsden NHS Foundation Trust, London, UK.
Eugenie YoungerSarcoma Unit, The Royal Marsden NHS Foundation Trust, London, UK.
Helena ChoPROFILES Team, The Royal Marsden NHS Foundation Trust, London, UK.
Clare PeckittResearch & Development, The Royal Marsden NHS Foundation Trust, London, UK.
Kabir MohammedResearch & Development, The Royal Marsden NHS Foundation Trust, London, UK.
Sheila MatharuDigital Services, The Royal Marsden NHS Foundation Trust, London, UK.
Lisa ScerriDigital Services, The Royal Marsden NHS Foundation Trust, London, UK.
Olga HussonDivision of Clinical Studies, Institute of Cancer Research, London, UK.
Susanne CruickshankApplied Health Research, The Royal Marsden NHS Foundation Trust, London, UK.
Rachel TurnerResearch & Development, The Royal Marsden NHS Foundation Trust, London, UK.
Linda WedlakePROFILES Team, The Royal Marsden NHS Foundation Trust, London, UK.
Royal Marsden NHS Foundation Trust · GBInstitute of Cancer Research · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundTo understand our performance with respect to the collection and reporting of patient-reported outcome (PRO) measure (PROM) data, we examined the protocol content, data completeness and publication of PROs from interventional trials conducted at the Royal Marsden NHS Foundation Trust (RM) and explored factors associated with data missingness and PRO publication.

designFrom local records, we identified closed, intervention trials sponsored by RM that opened after 1995 and collected PROMs as primary, secondary or exploratory outcomes. Protocol data were extracted by two researchers and scored against the SPIRIT-PRO (PRO protocol content checklist; score 0-100, higher scores indicate better completeness). For studies with locally held datasets, the information team summarized for each study, PRO completion defined as the number of expected (as per protocol) PRO measurements versus the number of actual (i.e. completed) PRO measurements captured in the study data set. Relevant publications were identified by searching three online databases and chief investigator request. Data were extracted and each publication scored against the CONSORT-PRO (PRO manuscript content checklist; scored as SPIRIT-PRO above). Descriptive statistics are presented with exploratory comparisons of point estimates and 95% confidence intervals.

resultsTwenty-six of 65 studies were included in the review. Nineteen studies had accessible datasets and 18 studies published at least one article. Fourteen studies published PRO results. Most studies had a clinical (rather than PRO) primary outcome (16/26). Across all studies, responses in respect of 35 of 69 PROMs were published. Trial protocols scored on average 46.7 (range 7.1-92.9) on the SPIRIT-PRO. Among studies with accessible data, half (10/19) had less than 25% missing measurements. Publications scored on average 80.9 (range 36-100%) on the CONSORT-PRO. Studies that published PRO results had somewhat fewer missing measurements (19% [7-32%] vs 60% [- 26 to 146%]). For individual PROMs within studies, missing measurements were lower for those that were published (17% [10-24%] vs 41% [18-63%]). Studies with higher SPIRIT-PRO scores and PROs as primary endpoints (13% [4-22%] vs 39% [10-58%]) had fewer missing measurements.

conclusionsMissing data may affect publication of PROs. Extent of inclusion of SPIRIT-PRO protocol items and PROs as primary endpoints may improve data completeness. Preliminary evidence from the study suggests a future larger study examining the relationship between PRO completion and publication is warranted.

Indexed as

CONSORT-PROData completenessMissing dataPREMsPROMsPROsSPIRIT-PRO

Identifiers

PMID36547735
PMCPMC9780410
OpenAlexW4312190517

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.